4/A//SEC Filing
Robbins Andrew R 4/A
Accession 0001209191-21-032965
CIK 0001708493other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 8:05 PM ET
Size
5.9 KB
Accession
0001209191-21-032965
Insider Transaction Report
Form 4/AAmended
Robbins Andrews R
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 totalExercise: $23.20Exp: 2031-05-03→ Common Stock (10,167 underlying)
Footnotes (2)
- [F1]This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error.
- [F2]The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4/A
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 8:05 PM ET
- Size
- 5.9 KB